Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
PARD stock price ended at $0 on Tuesday, after rising NaN%
On the latest trading day Jul 21, 2026, the stock price of PARD rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 31 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 100 shares were traded, amounting to a market value of approximately --.
PARD Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 6
Sell Signals 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
PARD currently exhibits 0 buy signals and 1 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for PARD
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for PARD. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to PARD?
According to technical analysis, Poniard Pharmaceuticals Inc has an aggregate signal of Sell. Poniard Pharmaceuticals Inc has 0 Buy signals, 6 Neutral Signals and 1 sell signals.
What is the RSI for Poniard Pharmaceuticals Inc?
The RSI for Poniard Pharmaceuticals Inc is currently 100.00, indicating a overbought condition
What is Poniard Pharmaceuticals Inc price for the next 12 months?
Poniard Pharmaceuticals Inc PARD price for the next 12 months is estimated at $0.
How high is Poniard Pharmaceuticals Inc expected to go?
According to wall street analysts, Poniard Pharmaceuticals Inc is expected to reach a high forecast of $0.